Manifest MedEx (MX), the largest nonprofit qualified health information organization (QHIO) for the CalHHS Data Exchange Framework (DxF), announced today it is securely exchanging permitted health data in real time on behalf of DxF participants, including with other QHIOs, marking…
Janux Therapeutics, a biopharmaceutical company listed on Nasdaq under the symbol JANX, has released its financial results for the fourth quarter and full year of 2023 alongside a comprehensive business update. In 2023, Janux made significant strides in evaluating its…
RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company dedicated to advancing precision oncology therapies through its local drug-delivery platform, announced today the significant promotions of Leesa Gentry to Chief Clinical Officer and Ronald B. Kocak, CPA to Principal Accounting Officer.…
LEO Pharma A/S, a global leader in medical dermatology, today presented for the first time key results from the DELTA 3 trial of delgocitinib cream, an investigational topical pan-Janus kinase (JAK)-inhibitor, at the 82nd American Academy of Dermatology (AAD) Congress in…
UnitedHealth Group reports significant strides in mitigating the effects of the cyberattack on the U.S. health system and the Change Healthcare infrastructure. Efforts focus on ensuring seamless access to care and medications for consumers and providers impacted by the attack.…
Signifier Medical Technologies, based in Boston, announces the publication of a study titled “Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea” in The International Journal of Technology Assessment in Health Care. Led by Drs. Shan…
Thermo Fisher Scientific Inc., a global leader in scientific solutions, has introduced a new CorEvitas syndicated clinical registry focusing on generalized pustular psoriasis (GPP). The registry, now open for enrollment, fills a crucial gap in real-world evidence (RWE) concerning clinical…
“Findhelp, a leading closed-loop referral management software company, is pleased to announce a partnership with Foothold Technology, a top provider of Human Services Electronic Health Record (EHR) and Care Coordination software. This collaboration aims to integrate mental and behavioral health…
LEO Pharma, a parent company of Timber Pharmaceuticals, Inc., presents initial findings from the ASCEND trial in a late-breaking session at the 2024 American Academy of Dermatology (AAD) Annual Meeting. The study provides a preliminary assessment of safety, efficacy, and…
Incyte (Nasdaq:INCY) disclosed findings from a Phase 2 trial examining povorcitinib (INCB54707), an oral JAK1 inhibitor’s effectiveness and safety among adult patients with prurigo nodularis (PN). These results were presented during a late-breaking oral session (Session: S050 – Late-Breaking Research:…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced positive results from the Phase 2 KARDIA-2 trial of zilebesiran, an RNAi therapeutic designed to treat hypertension by targeting liver-expressed angiotensinogen (AGT). The trial met its primary endpoint,…
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global leader in insulin delivery and diabetes technology, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement. This offering,…